Literature DB >> 20018971

Treatment of lung cancer.

Enzo Ballatori, Sonia Fatigoni, Fausto Roila.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018971     DOI: 10.1056/NEJMc0909634

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Model-free estimates that complement information obtained from the hazard ratio.

Authors:  Salil Vasudeo Deo; Vaishali Salil Deo; Varun Sundaram
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-04-05

2.  Statistical inference methods for two crossing survival curves: a comparison of methods.

Authors:  Huimin Li; Dong Han; Yawen Hou; Huilin Chen; Zheng Chen
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

3.  Analysis of time to event outcomes in randomized controlled trials by generalized additive models.

Authors:  Christos Argyropoulos; Mark L Unruh
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

4.  Knockdown of Tubulin Polymerization Promoting Protein Family Member 3 Suppresses Proliferation and Induces Apoptosis in Non-Small-Cell Lung Cancer.

Authors:  Yintao Li; Yali Xu; Kuanping Ye; Nan Wu; Junfeng Li; Naijia Liu; Min He; Bin Lu; Wenbai Zhou; Renming Hu
Journal:  J Cancer       Date:  2016-06-18       Impact factor: 4.207

5.  PIASy antagonizes Ras-driven NSCLC survival by promoting GATA2 SUMOylation.

Authors:  Bin Chen; Jie Luo; Yirui Zhou; Xu Xin; Rong Cai; Chunhua Ling
Journal:  J Cancer       Date:  2018-04-18       Impact factor: 4.207

6.  High Expression of Long Noncoding RNA PCNA-AS1 Promotes Non-Small-Cell Lung Cancer Cell Proliferation and Oncogenic Activity via Upregulating CCND1.

Authors:  Chuanyong Wu; Xiao-Ting Zhu; Lei Xia; Lin Wang; Wenjun Yu; Qiaomei Guo; Mingna Zhao; Jiatao Lou
Journal:  J Cancer       Date:  2020-01-29       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.